MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2019 International Congress

    Genotype-phenotype relations for the isolated Dystonia Genes TOR1A, THAP1, GNAL, ANO3, KMT2B, PRKRA and HPCA: MDSGene Systematic Review

    LM. Lange, J. Junker, S. Loens, L. Olschewski, S. Schaake, S. Petkovic, M. Kasten, A. Westenberger, A. Domingo, A. Madoev, I. König, C. Marras, KP. Bhatia, S. Camargos, C. Klein, K. Lohmann (Lübeck, Germany)

    Objective: To systematically review genotypes and phenotypes of monogenic isolated dystonia. Background: The Movement Disorder Society Genetic mutation database (MDSGene at www.mdsgene.org) provides an overview…
  • 2019 International Congress

    Is primary writing tremor a form fruste of dystonia?

    A. Latorre, L. Rocchi, A. Berardelli, J. Rothwell, K. Bhatia (Rome, Italy)

    Objective: To investigate whether primary writing tremor (PWT) and dystonia share a common pathophysiology and clarify if they are different phenomenological expressions of the same…
  • 2019 International Congress

    Bilateral Globus pallidus interna Deep Brain Stimulation in Cranio-Cervical Dystonia (Meige syndrome) patient in Hong Kong

    C. Lau, C. Zhu, D. Chan, K. Ma, L. Au, A. Chan, R. Wong, J. Yeung, W. Poon, V. Mok (Hong Kong, Hong Kong)

    Objective: To report the first cranio- cervical dystonia (Meige syndrome) patient who received Deep Brain Stimulation (DBS) implant in Hong Kong. Background: Meige syndrome is…
  • 2019 International Congress

    A novel heterozygous ANO3 mutation responsible for myoclonus-dystonia

    C. Laurencin, E. Broussolle, T. Danaila, M. Anheim, J. Chelly, S. Thobois (Lyon, France)

    Objective: We present a family carrying ANO3 mutation and exhibiting a myoclonus-dystonia and tremor phenotype. Background: Mutations of Anoctamine 3 gene (ANO3) are a rare…
  • 2019 International Congress

    Pediatric Deep Brain Stimulation in Secondary Dystonia using Stereotactic Depth Electrode Targeting

    M. Liker, T. Sanger (Los Angeles, CA, USA)

    Objective: The primary objective of our pediatric clinical research is to improve outcomes after deep brain stimulation for pediatric patients with secondary dystonia. We apply…
  • 2019 International Congress

    GPi DBS does not affect sensory thresholds in hereditary/idiopathic dystonia

    C. Listik, R. Gisbert Cury, V. da Silva, S. Carvalho Barbosa Casagrande, E. Listik, L. Link, R. Galhardoni, E. Reis Barbosa, M. Jacobsen Teixeira, D. de Andrade (Sao Paulo, Brazil)

    Objective: Despite the widespread use of DBS for dystonia, little is known about its effects on non-motor symptoms such as dystonia-related pain. Here we provide…
  • 2019 International Congress

    Combined Botulinum Toxin and Gpi DBS therapy in intractable cervical dystonia

    AM. Macerollo, BH. Hammersley, ME. Esposito, JS. Somerset, RE. Ellis, MB. Bonello, JP. Panicker, DD. Damodoran, JOF. Farah, PE. Eldridge, SA. Alusi (Naples, Italy)

    Objective: To test whether the reintroduction of Botulinum Toxin Injections (BTI) after Globus pallidus interna Deep Brain Stimulation (Gpi-DBS) for intractable cervical dystonia synergistically improves…
  • 2019 International Congress

    Two Patients with Dopamine Transporter Deficiency Treated with Deep Brain Stimulation

    J. Maclean, D. Ferman, T. Sanger, A. Tongol (Los Angeles, CA, USA)

    Objective: Dopamine transporter deficiency syndrome (DTDS,) a rare disease characterized by infantile –onset progressive dystonia, has no established treatment guidelines.  Treatment is generally predicated on…
  • 2019 International Congress

    The effect of Kinesio Taping therapy on Cervical Dystonia

    J. Magalhães, A. Rosso, F. Rezende (Rio de Janeiro, Brazil)

    Objective: To test the efficacy of kinesio taping treatment   as an adjunct therapy to botulinum toxin in the treatment of cervical dystonia. Background: Botulinum toxin…
  • 2019 International Congress

    Altered sensory processing in somatosensory and auditory domains in laryngeal dystonia

    T. Mantel, C. Dresel, M. Welte, C. Zimmer, B. Haslinger (Munich, Germany)

    Objective: To delineate correlates of altered sensory processing in laryngeal dystonia (LD) in both presence and absence of somatosensory input and their modulation by botulinum…
  • « Previous Page
  • 1
  • …
  • 1114
  • 1115
  • 1116
  • 1117
  • 1118
  • …
  • 1734
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley